In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otsuka Pharmaceutical Co. Ltd.

Division of Otsuka Holdings Co. Ltd.
www.otsuka.co.jp/en/

Latest From Otsuka Pharmaceutical Co. Ltd.

Pressure Builds On Lundbeck After Rexulti Fails In Bipolar I Manic Episodes

Rexulti failed in two Phase III trials to statistically separate from placebo in bipolar I manic episodes.

Business Strategies Commercial

VC Playbook: As China Looms, Sofinnova Partners Keeps The Faith In A Resilient Europe

In this first installment of VC Playbook, a new series profiling venture capital groups in biopharma and medtech, In Vivo talks to Antoine Papiernik, managing partner and chair of Sofinnova Partners – Europe’s largest and oldest VC devoted to the life sciences, with €2 billion under management.

Leadership Financing

Wellness Market News: Nuritas-Pharmavite Peptides, Abbott Nutriton, Brain Armor, Trade Group Notes

Pharmavite tests bioactive peptides with Nuritas' AI platform; NPA questions FDA proposal to share data collected from US firms; NFL great Randy White promotes Brain Armor supplements; Abbott Nutrition sales up 4.4% for 2018; ONHA targets expanding omega-3 testing among consumers; CRN's Mister, Sidley's Bass co-chair regulatory conference; and 'Hero for the Planet' Plotkin speaks at AHPA meeting.

Commercial Dietary Supplements

Innovation The Centerpiece In Mixed Japan 2019 Outlook

2019 has already brought one industry-shaking event in Japan with the formal completion of the Takeda-Shire deal. But how will this play out and what else can we expect in this key market over the next year?

Japan Commercial
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register